Vanguard Group’s Agios Pharmaceuticals AGIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $225M | Sell |
|
|||||
|
2025
Q2 | $189M | Buy |
|
|||||
|
2025
Q1 | $164M | Sell |
|
|||||
|
2024
Q4 | $185M | Buy |
|
|||||
|
2024
Q3 | $246M | Buy |
|
|||||
|
2024
Q2 | $237M | Sell |
|
|||||
|
2024
Q1 | $163M | Buy |
|
|||||
|
2023
Q4 | $123M | Buy |
|
|||||
|
2023
Q3 | $135M | Sell |
|
|||||
|
2023
Q2 | $156M | Buy |
|
|||||
|
2023
Q1 | $125M | Buy |
|
|||||
|
2022
Q4 | $150M | Buy |
|
|||||
|
2022
Q3 | $148M | Buy |
|
|||||
|
2022
Q2 | $115M | Buy |
|
|||||
|
2022
Q1 | $148M | Buy |
|
|||||
|
2021
Q4 | $167M | Sell |
|
|||||
|
2021
Q3 | $251M | Sell |
|
|||||
|
2021
Q2 | $308M | Sell |
|
|||||
|
2021
Q1 | $296M | Buy |
|
|||||
|
2020
Q4 | $244M | Buy |
|
|||||
|
2020
Q3 | $193M | Sell |
|
|||||
|
2020
Q2 | $307M | Buy |
|
|||||
|
2020
Q1 | $202M | Buy |
|
|||||
|
2019
Q4 | $268M | Buy |
|
|||||
|
2019
Q3 | $155M | Buy |
|
|||||
|
2019
Q2 | $231M | Sell |
|
|||||
|
2019
Q1 | $313M | Buy |
|
|||||
|
2018
Q4 | $213M | Buy |
|
|||||
|
2018
Q3 | $328M | Buy |
|
|||||
|
2018
Q2 | $349M | Buy |
|
|||||
|
2018
Q1 | $327M | Buy |
|
|||||
|
2017
Q4 | $189M | Buy |
|
|||||
|
2017
Q3 | $220M | Buy |
|
|||||
|
2017
Q2 | $165M | Buy |
|
|||||
|
2017
Q1 | $152M | Buy |
|
|||||
|
2016
Q4 | $103M | Buy |
|
|||||
|
2016
Q3 | $125M | Buy |
|
|||||
|
2016
Q2 | $88.2M | Buy |
|
|||||
|
2016
Q1 | $77.7M | Buy |
|
|||||
|
2015
Q4 | $121M | Buy |
|
|||||
|
2015
Q3 | $128M | Buy |
|
|||||
|
2015
Q2 | $180M | Buy |
|
|||||
|
2015
Q1 | $150M | Buy |
|
|||||
|
2014
Q4 | $145M | Buy |
|
|||||
|
2014
Q3 | $66.2M | Buy |
|
|||||
|
2014
Q2 | $39.3M | Buy |
|
|||||
|
2014
Q1 | $29.5M | Buy |
|
|||||
|
2013
Q4 | $5.89M | Sell |
|
|||||
|
2013
Q3 | $7.57M | Buy |
|